Literature DB >> 15215793

Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT.

Wei-Ching Chang1, Eric Boersma, Christopher B Granger, Robert A Harrington, Robert M Califf, Maarten L Simoons, Neal S Kleiman, Paul W Armstrong.   

Abstract

BACKGROUND: Risk assessment in patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) traditionally focuses on and is limited to admission findings. The objective of the current study was to develop an approach to predicting outcome in NSTE-ACS that could account for the changing nature of risk.
METHODS: In 7294 of 8010 patients with NSTE-ACS and complete electrocardiographic data in the GUSTO-IIb trial, we predicted the mortality probability at days 0-2, 0-30, 3-30, 5-30, and 7-30 using multiple logistic regression. Resulting risk estimates were incorporated into a composite, dynamic model to estimate the effects of changing probabilities over time. These models were validated against an independent sample of 9461 patients from the PURSUIT trial.
RESULTS: As time passed after admission, the risk of 30-day death declined in stable patients. This risk, which was 3.72% at baseline, declined to 1.92% in 6-day survivors, and the risk reduction was greatest for those with the highest baseline risk. Importantly, however, the development of inhospital complications modified these trends. The use of dynamic models not only allowed us to estimate early (<48 h) mortality with a high degree of accuracy (C-index of 0.87), but also to continuously update the longer-term prognosis with increasing accuracy: the C-index increased from 0.75 for the day 0-30 model to 0.81 and 0.82 for the composite and day 7-30 models, respectively.
CONCLUSIONS: Dynamic risk assessment is feasible and reliable. This approach can improve risk assessment and provide valuable guidance for management of patients with NSTE-ACS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15215793     DOI: 10.1016/j.ahj.2003.05.004

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

Review 1.  Explicit risk in acute coronary syndrome management.

Authors:  Merril L Knudtson; Colleen M Norris; P Diane Galbraith; Jaro Hubacek; William A Ghali
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

2.  Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations : A joint scientific statement from the Austrian Society of Cardiology and the Austrian Society of Hypertension.

Authors:  Thomas Weber; Irene Lang; Robert Zweiker; Sabine Horn; Rene R Wenzel; Bruno Watschinger; Jörg Slany; Bernd Eber; Franz Xaver Roithinger; Bernhard Metzler
Journal:  Wien Klin Wochenschr       Date:  2016-06-09       Impact factor: 1.704

3.  Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28.

Authors:  Matthew W Sherwood; David A Morrow; Benjamin M Scirica; Songtao Jiang; Christoph Bode; Nader Rifai; Robert E Gerszten; C Michael Gibson; Christopher P Cannon; Eugene Braunwald; Marc S Sabatine
Journal:  Am Heart J       Date:  2010-06       Impact factor: 4.749

4.  Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction.

Authors:  Renato D Lopes; Karen S Pieper; Susanna R Stevens; Scott D Solomon; John J V McMurray; Marc A Pfeffer; Jeffrey D Leimberger; Eric J Velazquez
Journal:  J Am Heart Assoc       Date:  2016-06-27       Impact factor: 5.501

5.  Impact of Admission Systolic Blood Pressure and Antecedent Hypertension on Short-Term Outcomes After ST-Segment Elevation Myocardial Infarction: Strobe-Compliant Article.

Authors:  Wenfang Ma; Yan Liang; Jun Zhu; Yanmin Yang; Huiqiong Tan; Litian Yu; Xin Gao; Guangxun Feng; Jiandong Li
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

6.  Blood Pressure Targets and Clinical Outcomes in Patients with Acute Myocardial Infarction.

Authors:  Hyukjin Park; Young Joon Hong; Jae Yeong Cho; Doo Sun Sim; Hyun Ju Yoon; Kye Hun Kim; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong; Jeong Gwan Cho; Jong Chun Park
Journal:  Korean Circ J       Date:  2017-07-12       Impact factor: 3.243

Review 7.  Optimal treatment of patients with NSTE-ACS in the Dutch health care system.

Authors:  J P van Kuijk; J M Ten Berg
Journal:  Neth Heart J       Date:  2018-06       Impact factor: 2.380

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.